Case Study

Accelerated ADC Approval Through Expert Modeling and Data Rescue

See how Certara rescued complex ADC PK datasets, delivered PopPK, exposure-response modeling, and enabled rapid…

CertaraDecember 15, 2025

Case Study

Merck Advances Pediatric Oncology with Innovative ADC Modeling

Merck leveraged ADC modeling and pediatric ADC dose optimization to enable FDA acceptance and advance…

CertaraDecember 12, 2025

Conference

ICoP 2026 India

Danielle PillsburyDecember 11, 2025

Blog

Virtual triplets: The next step in personalized and ethical drug development

Learn how virtual triplets, linking PBPK, QSP, and organ-on-a-chip technologies, are transforming model-informed drug development,…

CertaraDecember 9, 2025

On-Demand Webinar

Why Upgrade to Marvin? Unlocking Speed, Accuracy, and Scientific Intelligence

Watch this webinar to see how Marvin outperforms Marvin JS with faster chemical drawing, advanced…

CertaraDecember 8, 2025

Announcement

Certara Cuts Pharmacometrics Submission Timelines in Half: New Expedited Service Accelerates Global Regulatory Filings

Certara launches an expedited Pharmacometrics (PMx) Regulatory Submission service that cuts submission timelines in half.

CertaraDecember 3, 2025

Publication

Modeling amyloid plaque turnover dynamics improves characterization of drug effects

Researchers modeled how amyloid plaques form and clear in Alzheimer’s disease, helping explain how treatments…

CertaraNovember 26, 2025

Guide

10 Strategic Foundations for Early Drug Development

Discover effective Early Drug Development strategies to navigate early development with confidence and clarity. Download…

CertaraNovember 26, 2025

On-Demand Webinar

Seeing Across Species: Empiric Pharmacokinetic Time-Course Scaling in Phoenix®

Watch our on-demand webinar on empiric PK time-course scaling and learn how Certara’s translational experts…

CertaraNovember 13, 2025

Publication

Exposure–Response Analysis of Donidalorsen for the Treatment of Hereditary Angioedema

Certara and Ionis analyzed Phase 3 OASIS-HAE data showing flexible, effective donidalorsen dosing can reduce…

CertaraNovember 12, 2025

Drug Development